Table 3 Cross-tabulation of individual CMRFs (FBSL, HbA1c, TC and HDL) with the variables in study.
CMRFs | FBSL | HbA1c | TC | HDL | ||||
|---|---|---|---|---|---|---|---|---|
Total tests | Higher risk* results, n (%) | Total tests | Higher risk* results, n (%) | Total tests | Higher risk* results, n (%) | Total tests | Higher risk* results, n (%) | |
Rates | 193,496 | 16,259 (8.4) | 73,806 | 7,920 (10.73) | 194,624 | 57,506 (29.55) | 182,062 | 21,238 (11.67) |
Sex | ||||||||
Male | 83,603 | 9,279 (4.8) | 35,757 | 4,444 (6.02) | 90,950 | 23,503 (12.0) | 85,266 | 15,872 (8.72) |
Female | 109,893 | 6,980 (3.6) | 38,049 | 3,476 (4.71) | 103,674 | 34,003 (17.47) | 96,796 | 5,366 (2.95) |
Age (years) | ||||||||
18–29 | 19,747 | 238 (0.1) | 3,480 | 250 ( 0.34) | 14,247 | 2,127 (1.09) | 11,435 | 1,377 (0.76) |
30–39 | 23,515 | 459 (0.2) | 4,889 | 293 ( 0.40) | 18,960 | 4,889 (2.51) | 16,787 | 2,301 (1.26) |
40–49 | 29,424 | 1,265 (0.65) | 8,447 | 760 ( 1.03) | 31,395 | 10,719 (5.51) | 29,339 | 3,585 (1.97) |
50–59 | 37,085 | 2,948 (1.52) | 13,510 | 1,507 (2.04) | 39,663 | 16,316 (8.38) | 37,824 | 4,283 (2.35) |
60–69 | 37,962 | 4,670 (2.41) | 17,665 | 2,064 (2.80) | 40,471 | 13,620 (7.00) | 39,134 | 4,227 (2.32) |
70–79 | 29,009 | 4,396 (2.27) | 15,715 | 1,860 (2.52) | 31,186 | 6,748 (3.47) | 30,114 | 3,419 (1.88) |
80+ | 16,754 | 2,283 (1.18) | 10,100 | 1,186 (1.61) | 18,702 | 3,087 (1.59) | 17,429 | 2046 (1.12) |
IRSD | ||||||||
Most D Q-1 | 38,885 | 4,495 (2.32) | 17,024 | 2,429 (3.29) | 39,347 | 10,631 (5.46) | 36,625 | 5,520 (3.03) |
Q-2 | 41,545 | 3,757 (1.94) | 16,680 | 1,875 (2.54) | 41,937 | 12,015 (6.17) | 39,050 | 4,901 (2.69) |
Q-3 | 39,828 | 3,386 (1.75) | 15,376 | 1,585 (2.15) | 40,401 | 12,045 (6.19) | 37,794 | 4,201 (2.31) |
Q-4 | 37,137 | 2,594 (1.34) | 13,101 | 1,138 (1.54) | 36,865 | 11,163 (5.74) | 34,566 | 3,581 (1.97) |
Least D Q-5 | 36,101 | 2027 (1.05) | 11,625 | 893 (1.21) | 36,074 | 11,652 (5.99) | 34,027 | 3,035 (1.67) |
